Notice of Intent to Sole Source – Cardinal Health, Inc.
ID: 24-008994Type: Special Notice
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH - CCBETHESDA, MD, 20892, USA

NAICS

Surgical and Medical Instrument Manufacturing (339112)

PSC

MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES (6515)

Original Source

https://sam.gov/opp/bf629233b37e4d5da68743e125b1a671/view
Timeline
    Description

    The National Institutes of Health (NIH) intends to award a sole source contract to Cardinal Health, Inc. for the procurement of Floxuridine Vials, which are essential for patient care at the NIH Clinical Center in Bethesda, Maryland. The contract will involve a fixed price purchase order for 15 units of Floxuridine for Injection, catalog number 0143-9270-01, as Cardinal Health, Inc. is the only distributor of this medication in the United States. This acquisition is being conducted under the Federal Acquisition Regulation (FAR) Part 13, allowing for a sole source award due to the unique availability of the product. Interested parties may express their interest and capabilities by contacting Kristin Nagashima at kristin.nagashima@nih.gov by September 16, 2024, at 2 PM EST.

    Point(s) of Contact
    Kristin Nagashima
    kristin.nagashima@nih.gov
    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    Notice of Intent to Sole Source – Cardinal Health, Inc.
    Currently viewing
    Special Notice
    Similar Opportunities
    Notice of Intent to Sole Source – TheraDoc subscription
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) Clinical Center intends to award a firm fixed-price purchase order for subscription services related to the TheraDoc application, exclusively owned by Premier Healthcare LLC. This procurement aims to secure applications, support, maintenance, and training for the TheraDoc clinical surveillance solution, which is critical for enhancing healthcare delivery and patient safety. The acquisition will follow the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, allowing for a sole-source solicitation due to the unique nature of the services required. Interested parties may express their capabilities and submit comments to the NIH by November 21, 2024, with inquiries directed to Ryssa Nix at Ryssa.nix@nih.gov.
    Hardy Diagnostic Reagents and Supplies
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to award a sole-source contract to Hardy Diagnostics for the procurement of culture media and organism supplies necessary for cGMP Sterility Testing Services. The primary objective is to ensure compliance with FDA regulations by utilizing cGMP quality materials that have been rigorously validated, as these supplies are critical for the isolation and identification of pathogens affecting critically ill patients. The contract will cover a base period of twelve months with an option for an additional three months, and interested vendors capable of providing similar products are encouraged to submit capability statements by the specified deadline. For further inquiries, potential respondents may contact Kimala Winfield at kimala.winfield@nih.gov or Malinda Dehner at dehnerm@cc.nih.gov.
    J--Maintenance Contract for BD Fortessa Flow Cytometer Analyzer
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to award a sole source maintenance contract for the BD Fortessa Flow Cytometer Analyzer. The contract will be awarded to Becton, Dickinson and Company, which is uniquely qualified to provide comprehensive maintenance services, including emergency repairs and two annual preventative visits, due to the proprietary nature of the cytometer's configurations tailored for the NIH's research needs. This specialized equipment is critical for ongoing research in hematology, necessitating high uptime to support scientific advancements. Interested parties may express their capabilities, with responses due by January 17, 2025; for further inquiries, contact Helmut A. Winffel at helmut.winffel@nih.gov or +1 301 435 0330.
    Notice of Intent to Sole Source – Articulate Global
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a sole source contract to Articulate Global, LLC for the renewal of licenses for the Articulate 360 suite of e-learning authoring tools. This procurement aims to provide the NIH Clinical Center Nursing Department with continued access to a suite of customizable tools essential for developing and maintaining over 60 online courses that have been created since 2015. The renewal is critical as it allows the Nursing Department to efficiently update existing courses without the need to transition to a new vendor, which would significantly disrupt their operations. Interested parties may express their interest and capabilities by contacting Kristin Nagashima, Contract Specialist, via email at Kristin.nagashima@nih.gov by January 17, 2025, at 5 PM EST.
    Gore Medical branded stents (Brand Name restriction)
    Health And Human Services, Department Of
    The Department of Health and Human Services, National Institutes of Health seeks to procure specific medical devices for use in interventional radiology procedures. These are brand-restricted items, with the National Institute of Health specifying Gore Medical branded stents. The scope of work involves supplying several variants of two medical devices: Viatorr Tips Endo CX and Viabahn BX Balloon Expander Endo. The Viatorr Tips are measured in millimeters and vary in length, while the Viabahn BX Balloon Expanders are used in catheterization procedures. The medical devices are intended for minimally invasive procedures. The bill of materials provided outlines the exact models and quantities sought. Offerors must provide the following: 1 unit of Model PTB8105275, ID 00733132635016 - 8-10mmX5cm/2cm 10Fr VIATORR TIPS ENDO CX 1 unit of Model PTB8107275, ID 00733132635030 - 8-10mmX7cm/2cm 10Fr VIATORR TIPS ENDO CX 1 unit of Model PTB8108275, ID 00733132635047 - 8-10mmX8cm/2cm 10Fr VIATORR TIPS ENDO CX 1 unit of Model BXB083901A, ID 00733132658718 - 8MMX39MM 7Fr 80CM Cath RP VIABAHN BX BALLOON EXP ENDO 1 unit of Model BXB085901A, ID 00733132658732 - 8MMX59MM 7Fr 80CM Cath RP VIABAHN BX BALLOON EXP ENDO Eligible applicants should be well-established surgical and medical instrument manufacturers (NAICS code 339112) with the ability to deliver the specified devices promptly. The evaluation of quotes will consider technical capability, price, and past performance. Quotes should be submitted to Lu Chang at lu-chang.lu@nih.gov by 5:00 PM EST on 08/01/2024, including the RFQ number (RFQ-CC-24-010258) in the subject line. Further inquiries can be directed to the same email address. This opportunity is a combined synopsis and solicitation issued under FAR Subpart 12.6. The resulting contract will be a firm fixed-price order.
    Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking proposals for Chemistry, Manufacturing, and Controls (CMC) services to support the development of drug products. The objective of this procurement is to ensure the delivery of high-quality formulated drug products for preclinical, IND-enabling, and clinical studies, which are critical for advancing therapeutic development. This opportunity encompasses a wide range of services, including formulation development, manufacturing under current Good Manufacturing Practices (cGMP), and necessary testing to meet regulatory standards. Proposals are due by February 3, 2025, with a contract period extending from September 30, 2025, to July 31, 2031, and a maximum funding amount of $49,885,703. Interested parties can contact Michelle Cecilia at michelle.cecilia@nih.gov or Valerie Whipple at valerie.whipple@nih.gov for further information.
    CONSUMABLES FOR HYDROPAC WATERING SYSTEM
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking quotes for consumables for the Hydropac watering system, as outlined in solicitation number RFQ-NIAID-25-2254249. The primary requirement includes a Hydropac Master Carton containing 72,000 valves and 36 rolls of pouch film, which are essential for the operational effectiveness of the NIH in managing infectious diseases. This procurement is structured under the Federal Acquisition Regulation (FAR) Subpart 12.6 for commercial items, emphasizing a brand name restriction to ensure compatibility with existing systems. Interested vendors must submit their offers by January 22, 2025, to Calvin Robinson at calvin.robinson@nih.gov, and must be registered in the System for Award Management (SAM) prior to award.
    Preventative Maintenance 10x Genomics Chromium iX/X
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to award a sole-source contract to 10x Genomics, Inc. for preventative maintenance of the Chromium X single cell capture system, which is critical for ongoing research in neural regeneration. The contract aims to ensure the operability of the equipment, minimize downtime, and support the generation of sequencing libraries necessary for the Molecular Neurobiology Section's research efforts. This maintenance service is essential for maintaining the functionality of the proprietary equipment, which requires OEM-certified technicians and compatible parts, as no alternative suppliers are available. Interested parties can contact Frederick Weddington at frederick.weddington@nih.gov or by phone at 301-594-6835, with the response date for proposals set for January 17, 2025, and the performance period expected to run from January 27, 2025, to January 26, 2030.
    NIAID CLINICAL PRODUCTS CENTER (CPC)
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking proposals for a contract to provide pharmacy and pharmaceutical oversight for clinical trials, both nationally and internationally. The primary objective of this contract is to ensure the integrity of study products, participant safety, and compliance with pharmacy and pharmaceutical regulations throughout various NIH-funded clinical trials. This opportunity is critical for maintaining high standards in public health research, as it encompasses a wide range of services including product management, regulatory document maintenance, and clinical laboratory testing. Proposals are due by January 17, 2025, with the contract expected to commence on April 1, 2026, and run through March 31, 2027, potentially extending through 2033. Interested parties can contact Deborah Blyveis at blyveisd@niaid.nih.gov or Emily Bannister at emily.bannister@nih.gov for further information.
    Cambridge Isotope L-Glutamine
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified small businesses to provide L-Glutamine enriched with stable isotope 13C for neuroscience research. The procurement aims to secure domestically manufactured chemicals that are essential for enhancing carbon-13 MR spectroscopy signals, which are critical for studying brain metabolism and measuring important metabolites. This initiative underscores the importance of maintaining a domestic supply of these chemicals to support ongoing research efforts at NIH and NIMH. Interested parties must submit their responses, including company information and capability statements, electronically to Joseph Kennedy at joseph.kennedy@nih.gov by January 22, 2025, as the anticipated contract duration is 12 months.